This episode delves into the most common and costly mistakes medical technology companies make when seeking EU MDR compliance. We break down the complexities of technical documentation, clinical evidence requirements, risk management, and post-market surveillance, offering actionable strategies to avoid these pitfalls, streamline your submission process, and prevent significant delays and rejections from Notified Bodies. Key Questions: • Is your technical documentation truly 'reviewer-ready'? • Are you underestimating the new bar for clinical evidence under the MDR? • Does your risk management file accurately reflect your device's entire lifecycle? • Is your Post-Market Surveillance (PMS) plan proactive or just reactive? • How can you avoid the most common reasons for Notified Body pushback? • What makes a Clinical Evaluation Report (CER) robust enough for the MDR? • Are inconsistencies in your documentation putting your submission at risk? Ready to turn these insights into your competitive edge? Pure Global’s regulatory experts guide MedTech companies through every step of 30+ markets worldwide. Explore how we can accelerate your market entry at https://pureglobal.com or email [email protected] for tailored support.